These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15967554)

  • 21. Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?
    Dusseldorp E; Spinhoven P; Bakker A; van Dyck R; van Balkom AJ
    Psychother Psychosom; 2007; 76(3):154-61. PubMed ID: 17426414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissemination of exposure therapy in the treatment of posttraumatic stress disorder.
    Cahill SP; Foa EB; Hembree EA; Marshall RD; Nacash N
    J Trauma Stress; 2006 Oct; 19(5):597-610. PubMed ID: 17075914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The startle reflex in alcohol-dependent patients: changes after cognitive-behavioral therapy and predictive validity for drinking behavior. A pilot study.
    Loeber S; Croissant B; Nakovics H; Zimmer A; Georgi A; Klein S; Diener C; Heinz A; Mann K; Flor H
    Psychother Psychosom; 2007; 76(6):385-90. PubMed ID: 17917475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How does dialectical behavior therapy facilitate treatment retention among individuals with comorbid borderline personality disorder and substance use disorders?
    Bornovalova MA; Daughters SB
    Clin Psychol Rev; 2007 Dec; 27(8):923-43. PubMed ID: 17376574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The exposure hierarchy as a measure of progress and efficacy in the treatment of social anxiety disorder.
    Katerelos M; Hawley LL; Antony MM; McCabe RE
    Behav Modif; 2008 Jul; 32(4):504-18. PubMed ID: 18525064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches.
    Davis M; Barad M; Otto M; Southwick S
    J Trauma Stress; 2006 Oct; 19(5):571-81. PubMed ID: 17075906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addiction motivation reformulated: an affective processing model of negative reinforcement.
    Baker TB; Piper ME; McCarthy DE; Majeskie MR; Fiore MC
    Psychol Rev; 2004 Jan; 111(1):33-51. PubMed ID: 14756584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Language and emotions: emotional Sapir-Whorf hypothesis.
    Perlovsky L
    Neural Netw; 2009; 22(5-6):518-26. PubMed ID: 19616406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders.
    Siev J; Chambless DL
    J Consult Clin Psychol; 2007 Aug; 75(4):513-22. PubMed ID: 17663606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.
    Bukstein OG
    Expert Rev Neurother; 2006 Apr; 6(4):541-9. PubMed ID: 16623653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological and psychological interventions: trends in substance use disorders intervention research.
    Wessell R; Edwards C
    Addict Behav; 2010 Dec; 35(12):1083-8. PubMed ID: 20729001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative reinforcement eating expectancies, emotion dysregulation, and symptoms of bulimia nervosa.
    Hayaki J
    Int J Eat Disord; 2009 Sep; 42(6):552-6. PubMed ID: 19172595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychologic principles of substance abuse: a brief overview.
    Liese BS
    Compr Ther; 1994; 20(2):125-9. PubMed ID: 8205765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posttraumatic stress disorder: a state-of-the-science review.
    Nemeroff CB; Bremner JD; Foa EB; Mayberg HS; North CS; Stein MB
    J Psychiatr Res; 2006 Feb; 40(1):1-21. PubMed ID: 16242154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of relapse to substance use in comorbid adolescents.
    Ramo DE; Anderson KG; Tate SR; Brown SA
    Addict Behav; 2005 Oct; 30(9):1811-23. PubMed ID: 16139961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive-behavioral stress management for individuals with substance use disorders: a pilot study.
    Back SE; Gentilin S; Brady KT
    J Nerv Ment Dis; 2007 Aug; 195(8):662-8. PubMed ID: 17700298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cue exposure and learning theory.
    Hammersley R
    Addict Behav; 1992; 17(3):297-300. PubMed ID: 1353283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are treatments for common mental disorders also effective for functional symptoms and disorder?
    Mayou R
    Psychosom Med; 2007 Dec; 69(9):876-80. PubMed ID: 18040098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.